NVP-BEZ235 (Dactolisib) Has Protective Effects in a Transgenic Mouse Model of Alzheimer's Disease
Alzheimer's disease (AD) is a neurodegenerative disease and the main cause of dementia. Its major symptom is memory loss, which is a result of neuronal cell death, which is accompanied by neuroinflammation. Some studies indicate the overactivation of the phosphatidylinositol 3-kinase (PI3K)/pro...
Saved in:
Main Authors: | Paula Maria Quaglio Bellozi (Author), Giovanni Freitas Gomes (Author), Leonardo Rossi de Oliveira (Author), Isabella Guimarães Olmo (Author), Érica Leandro Marciano Vieira (Author), Fabíola Mara Ribeiro (Author), Bernd L. Fiebich (Author), Antônio Carlos Pinheiro de Oliveira (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antitumor efficacy of liposome-encapsulated NVP-BEZ 235 in combination with irreversible electroporation
by: Li Tian, et al.
Published: (2018) -
NVP-BEZ235 Inhibits Renal Cell Carcinoma by Targeting TAK1 and PI3K/Akt/mTOR Pathways
by: Bihui Li, et al.
Published: (2022) -
Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines
by: Xin P, et al.
Published: (2017) -
A phase I study of a dual PI3-kinase/mTOR inhibitor BEZ235 in adult patients with relapsed or refractory acute leukemia
by: Fabian Lang, et al.
Published: (2020) -
Impact of a Mobile Application for Tracking Nausea and Vomiting During Pregnancy (NVP) on NVP Symptoms, Quality of Life, and Decisional Conflict Regarding NVP Treatments: MinSafeStart Randomized Controlled Trial
by: Elin Ngo, et al.
Published: (2022)